| abstract |
A method of treating a patient in need of therapy for a cytokine dysregulation comprising administering to that patient a therapeutically effective dose of a compound of general formula: (I) wherein R 1 and R 2 together form a group —(CH 2 ) n —CR 4 R 5 —(CH 2 ) m — wherein n and m are independently selected integers 0, 1 or 2 and R 4 and R 5 are independently selected from H, C 1-18 alkyl, C 1-18 alkoxy, C 1-18 hydroxyalkyl, C 2-18 alkenyl and C 6-18 aryl or aralykyl and R 3 is the a fatty acyl group of an essential polyunsaturated fatty acid. |